MA
AMPH icon

MCF Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

MCF Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.96K Buy
+100
New +$2.45K ﹤0.01% 1202

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

MCF Advisors's AMPH Position: Q1 2026 in Review

MCF Advisors opened a new position in Amphastar Pharmaceuticals (AMPH) in Q1 2026: 100 shares worth $1.96K. The stake represents ﹤0.01% of the portfolio and ranks #1202 among its holdings.

215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • MCF Advisors held 100 shares of Amphastar Pharmaceuticals worth $1.96K as of Q1 2026.
  • Amphastar Pharmaceuticals was a new MCF Advisors position in Q1 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of MCF Advisors's portfolio in Q1 2026, its #1202 holding.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.